SCHEMBL18883104

SCHEMBL18883104

CCc1c[nH]n(-c2ccc(Br)cc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.39
ALKBH5 Q6P6C2 1/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRA6 Q16445 1/20 0.36
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DDAH1 O94760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23400864 0.84 ALDH1A1 (0.57) ALDH1A1MAPTHPGDHSD17B10MGLL
SCHEMBL23400948 0.82 MAPT (0.55) ALDH1A1MAPTHPGDPOLBNPSR1
SCHEMBL23402328 0.73 ALDH1A1 (0.54) ALDH1A1MAPTHPGDHSD17B10MGLL
SCHEMBL5599513 0.73 ALDH1A1 (0.80) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL23398602 0.72 ALKBH5 (0.44) ALDH1A1MAPTALKBH5HSD17B10MGLL
SCHEMBL21821548 0.71 ALKBH5 (0.50) ALDH1A1MAPTALKBH5GABRA1GABRG2
SCHEMBL23401874 0.71 MAPT (0.51) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL23402021 0.71 ALDH1A1 (0.51) ALDH1A1MAPTHPGDHSD17B10NPC1
SCHEMBL23399880 0.69 ALDH1A1 (0.49) ALDH1A1MAPTHPGDHSD17B10MGLL
SCHEMBL23398411 0.69 MAPT (0.49) ALDH1A1MAPTNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043623-B2 Purinones as ubiquitin-specific protease 1 inhibitors FORMA THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-20170145012-A1 PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS FORMA THERAPEUTICS, INC. 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170145012-A1 PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS USP1, UBA1, UBXN1 ALDH1A1 633/4885MAPT 3373/4885ALKBH5 3983/4885
US-12043623-B2 Purinones as ubiquitin-specific protease 1 inhibitors USP1, UBA1, UBXN1 ALDH1A1 633/4885MAPT 3373/4885ALKBH5 3983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.